G7 agrees 1 billion COVID vaccine donation - communique
Group of Seven countries will provide 1 billion COVID-19 vaccine doses over the next year and work with the private sector, the G20 and other countries to increase the contribution over months to come, according to an almost finalised draft of the communique.
- Country:
- United Kingdom
Group of Seven countries will provide 1 billion COVID-19 vaccine doses over the next year and work with the private sector, the G20, and other countries to increase the contribution over months to come, according to an almost finalized draft of the communique. "The commitments since we last met in February 2021 including here in Carbis Bay provide for 1 billion doses over the next year," said the communique, seen by Reuters.
"We will work together with the private sector, the G20, and other countries to increase this contribution over the months to come," the communique said. Two sources said the draft had been largely finalized by diplomats who worked late into Saturday night to agree on most of the text, though they said parts of the draft could change over coming hours.
There were few disagreements over the communique, which is going through final drafting, though Japan pushed for a tougher line on China, a diplomatic source said. The G7 said in the draft that the vaccine donations built on exports from domestic production with at least 700 million doses exported or to be exported this year, of which at least 50% have gone to non G7 countries.
The group added that it had "a commitment to continue exporting in significant proportions; and the promotion of voluntary licensing and not-for-profit global production, which has so far accounted for 95% of the COVAX supply," the communique said. The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), aims to secure 2 billion vaccine doses for lower-income countries by the end of 2021.
"We reaffirm our support for all pillars of the ACT-A across treatments, tests, and strengthening public health systems as well as vaccines," the communique said. The ACT-Accelerator partnership was designed to accelerate the design, production, and distribution of vaccines.
"We support discussions regarding the extension of the ACT-A mandate into 2022, noting the planned comprehensive review to optimize its effectiveness and accountability."
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Battling climate change, Japan looks to seagrass for carbon capture
Partnership on the Horizon: India and Japan Forge SME Association
Ramen: A Culinary and Cultural Tapestry of Japan, Enchanting Tourists with Its Flavors and Traditions
Japan frets over relentless yen slide as BOJ keeps ultra-low rates
Sharma Misses Cut in Japan; Four-Way Tie at Top